The concentration of soluble transferrin receptor (sTfR) in serum is reported to be useful in the diagnosis of iron deficiency, especially for patients with concurrent chronic disease, where routine tests of iron status are compromised by the inflammatory condition. A new diagnostic assay for sTfR is calibrated against natural plasma sTfR, thus minimizing calibration discrepancies that result from differences between the analyte and the cellular transferrin receptor used in other assays. Use of the new assay to measure sTfR concentrations in 225 healthy, hematologically normal adults provided a reference interval against which pathological samples could be compared. There was no difference in the reference intervals for men and women and no correlation of [sTfR] with the age of the subject. Black subjects had significantly higher concentrations than nonblacks, and people living at high altitude had higher concentrations than those living closer to sea level. These differences were additive.
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The uptake of iron by cells is mediated by a transferrin receptor (TfR) 6 [1] expressed on their external surface (reviewed in ref.
2). TfR binds diferric transferrin, and the receptor-transferrin complex is internalized into an endosome, where the iron is transferred to the cytosol. After recycling to the cell surface, the apotransferrin dissociates, and the receptor is free to repeat the process. Cells deficient in iron upregulate expression of TfR to compete more successfully for available iron [2] [3] [4] .
TfR is a disulfide-linked dimer of two identical 85-kDa subunits [1, 2, 5, 6] . Each subunit has a 61-amino acid N-terminal cytoplasmic domain, a transmembrane region, and a large extracellular domain. TfR is shed from cells by proteolytic cleavage at Arg 100 -Leu 101 [7, 8] , just external to the plasma membrane and just after the two interchain disulfide bonds. The product circulates in the blood as soluble TfR (sTfR), a 74-kDa monomer [9] bound to transferrin. The amount of circulating sTfR is proportional to the total amount of cell-associated TfR [10] .
Because TfR expression is upregulated when a cell needs more iron and because sTfR is proportional to total TfR, concentrations of sTfR, [sTfR] , are increased in plasma or serum of an iron-deficient subject. Some have found the concentration of serum sTfR useful in the diagnosis of iron deficiency [4, [11] [12] [13] , especially in patients with chronic inflammatory, infectious, or malignant disease [14 -17] , where the usual tests of iron status may be misleading. There has, however, been no comprehensive evaluation of reference interval data for effective use of sTfR as a diagnostic tool. In iron deficiency, [sTfR] increases to about twice the normal concentration [16, 17] , but the distribution of values is broad enough that the 95% ranges may overlap. This makes it important to have a reliable and precise assay system, as well as a wellestablished reference interval and an understanding of the factors that influence it.
We describe here a new assay for the measurement of sTfR as an aid in the diagnosis of iron deficiency, and we report the reference interval of [sTfR] in healthy adults. We investigated the effects of sex, race, age, and altitude of residence-factors known to affect other hematological variables.
Materials and Methods
Preparation of monoclonal antibodies. Monoclonal antibodies were from hybridoma mouse cells prepared with standard protocols for immunization [18] , fusion [19] , selection of hybrid cells [20] , and screening for positive clones. Immunization was with human placental TfR purified according to Turkewitz et al. [21] .
Among several screening assays, the most important was for antibodies that could capture sTfR from a pool of normal human serum. We evaluated 14 antibodies, choosing 1 for purification of sTfR from plasma by immunoaffinity chromatography and 2 for use in the sTfR assay.
Preparation of the master calibrator. To assure uniformity of future lots of ELISA kits, we prepared a large batch of highly purified and well-characterized plasma sTfR for lyophilization in many small aliquots for use as a master calibrator. The method was adapted from that of Shih et al. [7] . A fraction precipitated by ammonium sulfate saturated between 40% and 60% was dissolved in a minimum volume of phosphate-buffered saline (PBS; 137 mmol/L NaCl, 8.1 mmol/L Na 2 HPO 4 , 1.5 mmol/L KH 2 PO 4 , 2.7 mmol/L KCl, and 0.2 g/L NaN 3 , pH 7.4) and then dialyzed against the same buffer. The retentate was chromatographed on an affinity column of immobilized anti-TfR monoclonal antibody (different from those used in the assay kit). sTfR plus sTfR-bound transferrin were retained on the column. After the column was washed with PBS, transferrin was eluted with 0.5 mol/L NaSCN in PBS. After a further wash with 10 column volumes of PBS, sTfR was eluted with ethylene glycol, 250 mL/L in 0.1 mol/L triethylamine (pH 11.5). The eluate was dialyzed against 20 mmol/L Tris (pH 8.0), filtered through a 0.2-m pore-size filter, and chromatographed on a Mono-Q HPLC column (Pharmacia). This elution was made with a gradient from 0 to 0.5 mol/L NaCl in 20 mmol/L Tris (pH 8.0). Fractions from the column were then run on nonreducing 5-15% polyacrylamide gels. Fractions with pure sTfR were pooled and dialyzed against PBS without azide.
The authenticity and purity of sTfR were established by N-terminal sequence analysis, by sodium dodecyl sulfate-polyacrylamide gel electrophoreses (SDS-PAGE), and by analysis of amino acid composition, and all results were compared with published data. The mass of purified protein was calculated from the amino acid analysis. The ratio of mass to ELISA immunoreactivity of the master calibrator sTfR and of partially purified sTfR (mass estimated by quantitative SDS-PAGE) established that the extensive purification did not modify the immunoreactivity of the sTfR.
Preparation of kit calibrators. To obtain a sufficient yield of sTfR for kit calibrators, we modified the preparation of pure sTfR by elimination of the final Mono-Q column and the chaotropic removal of transferrin from sTfR on the immunoaffinity column. The process resulted in a high yield of material that was 35-45% sTfR. Calibrators were prepared from this material by reference to the immunoreactivity of the master calibrator.
sTfR assay. The assay operates on the quantitative two-site immunoenzymometric ("sandwich") technique. A monoclonal antibody specific for sTfR is precoated onto the wells of a microplate. Then, 20 L of calibrator or sample and 100 L of assay diluent are added to the wells and incubated for 1 h, during which sTfR becomes bound to the immobilized antibody. After any unbound material is washed away, 100 L of a second monoclonal antibody conjugated to horseradish peroxidase is added and incubated for 1 h, during which the conjugate binds to the captured sTfR. After another washing away of unbound material, the amount of bound conjugate is detected by reaction for 30 min with a specific substrate, which yields a colored product that is proportional to the amount of conjugate (and thus to the amount of sTfR in the sample).
The color reaction is stopped with hydrochloric acid, and the concentration of sTfR in each well is read from a calibration curve of absorbance vs [sTfR] .
Sample collection. Three hundred healthy, adult, paid volunteers were recruited by advertisement at four centers, three at or below an altitude of 300 m (New York, Cincinnati, and Minneapolis) and one at 1600 m (Denver) above sea level. The study was approved by the Institutional Review Board at each center, and informed consent was obtained in writing from all subjects. Pregnant women, recent or frequent blood donors, and persons taking prescribed medication (except hormone contraceptives or hormone replacement therapy) were excluded.
Brief demographic data (age, sex, pre-or postmenopausal status, racial group, and illness in the past 6 months) were collected by interview, and a blood sample of 25 mL was drawn by venipuncture. Of this, 5 mL was drawn into anticoagulant; the remainder was allowed to clot and was then centrifuged to separate the serum. The whole blood and 5 mL of the serum were sent to a reference laboratory (Laboratory Corporation of America, Raritan, NJ) for a complete blood count and determination of iron status (serum ferritin, serum iron, total-iron binding capacity, and transferrin saturation). The remaining serum was stored in 200-L aliquots at Ϫ70°C until the end of the study, after which one aliquot was thawed and analyzed for sTfR.
Statistical analysis.
A multifactorial analysis of variance was used to assess the effects of sex, pre-or postmenopausal status in women, race (FDA classification [22] ), and altitude on sTfR concentration. The effect of age was investigated by regression analysis (MacAnova, School of Statistics, University of Minnesota, St. Paul, MN; Statistica, StatSoft, Tulsa, OK).
Results and Discussion
Assay characteristics. The assay was calibrated with [sTfR] from 3 to 80 nmol/L; values outside this range were not read. The minimum detectable dose, calculated as the concentration represented by 2 SD above the mean of 20 replicates of the zero calibrator, was 0.5 nmol/L. There was no cross-reactivity with human diferric transferrin or apotransferrin or with ferritin from human heart, liver, or spleen. Intraassay precision was assessed by measuring 20 replicates of three samples at one time. The means and (CVs) were 6.9 (4.3%), 18.2 (7.1%), and 40.2 (6.2%) nmol/L. Interassay precision was assessed by measuring three samples in 60 separate assays spread over 3 months, with use of three batches of reagents by multiple operators. The means (and CVs) were 10.9 (6.4%), 25.7 (5.4%), and 67.2 (5.7%) nmol/L.
Linearity was established by serial dilution of five serum samples supplemented with sTfR to concentrations of 52-70 nmol/L (i.e., from 65% to 88% of the highestconcentration calibrator). Dilutions from 1:2 to 1:16 with sample diluent showed a mean recovery of 101% (range 95-111%). Analytical recovery was established by addition of sTfR (16, 32, Calibration against plasma sTfR was intended to improve the accuracy of the assays results. Assays used in published studies had been calibrated with cellular disulfide-linked dimeric TfR from placenta. This introduces inherent uncertainty about whether the dimer behaves in the assay the same as two monomers would and whether dimer-specific or dimer-masked epitopes are involved in the assay. The difficulty of assigning a value to a calibrator that differs from the analyte is illustrated by the different mean values quoted for normal adults for other assays. The published means vary from 0.25 mg/L [23] to 5.36 mg/L [14] . For comparison, the mean reported here, 19.6 nmol/L, corresponds to 1.47 mg/L, or 1.66 mg/L of a single subunit of intact cellular TfR. sTfR reference interval. Data from 225 subjects were used in the statistical analysis (Table 1) . Seventy-five of the 300 subjects recruited were omitted from the calculation, because either data were missing, entry criteria were not observed, or the complete blood counts and iron status assays indicated anemia, abnormalities of erythrocyte production, iron deficiency, or iron overload (Table 2) .
Individual [sTfR] ranged from 7.6 to 37.7 nmol/L (mean ϭ 19.6 Ϯ 5.0); their apparent conformation to gaussian distribution (Fig. 1) was verified with a ShapiroWilk test (W ϭ 0.976, P ϭ 0.1). There was no correlation with age (range 19 -79 years, r ϭ 0.008, P ϭ 0.901), and there were no statistically significant differences between men and women (consistent with previous reports [23, 24] ) or between pre-and postmenopausal women.
Two statistically significant differences were observed, however. First, black subjects had ϳ9% higher values for [sTfR] than did Caucasians, Asians, and Hispanics, whereas values for the latter three groups did not differ significantly. The difference may be related to the wellknown but unexplained difference in hemoglobin concentrations ([Hb]) in blacks vs Caucasians (concentrations in blacks being ϳ5 g/L less [25] ). Second, subjects residing at high altitude had concentrations ϳ9% higher than those nearer to sea level. To eliminate the possibility that the difference at high altitude could be due to the inclusion in Denver of individuals who might be regarded as anemic, the mean [sTfR] was recalculated for this site, but with the lower limits of the reference ranges for [Hb] at the University of Colorado Hospital (135 and 145 g/L for women and men, respectively) being used as the cutoff values for inclusion in this study. The effect on the mean [sTfR] was minimal: 20.8 nmol/L with lower cutoff, 20.9 with higher cutoff. Because these two effects, race and altitude, were independent and additive, separate 95% reference intervals (mean Ϯ 2 SD) were calculated for black and nonblack subjects at low and high altitudes ( Table 3) . The correlations between [sTfR] and the variables related to erythrocyte production were weak but statistically significant: Hb (r ϭ 0.304, P Ͻ0.001, Fig. 2 Of 300 subjects recruited for this study, many of whom were employees of major health facilities, 25% were excluded for hematological reasons. In this study we set rigorous inclusion criteria to ensure a truly "normal" population. For more-routine determinations of the reference interval for [sTfR] , only individuals with iron deficiency or an abnormal erythrocyte profile need to be excluded (see Table 2 ).
With a sufficiently large population, an alternative 
